Company profile: Presidio Medical
1.1 - Company Overview
Company description
- Provider of a transformational neuromodulation platform and ULF Neuromodulation Therapy, which uses ultra low frequency current waveforms to inhibit pain signals; shown effective in clinical trials for chronic pain without causing paresthesia, enabling remedies for disorders affecting neuronal activity.
Products and services
- Transformational Neuromodulation Platform: Platform-scale neuromodulation system that enables delivery of remedies for disorders affecting neuronal activity, architected to modulate neuronal activity for therapeutic effect
- ULF Neuromodulation Therapy: Clinically-validated neuromodulation therapy that inhibits pain signals using ultra low frequency current waveforms, demonstrating effectiveness for chronic pain treatment without causing paresthesia in clinical evaluations
- Chronic Pain Treatment (ULF Therapy): Paresthesia-free application of ULF neuromodulation that targets chronic pain by inhibiting pain signal transmission using ultra low frequency current waveforms demonstrated effective in clinical trials
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Presidio Medical
mdgroup
HQ: United Kingdom
Website
- Description: Provider of professional services to a wide range of industries, with a focus in the life sciences sector. Women-owned, independent global organisation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full mdgroup company profile →
Quotient Sciences
HQ: United Kingdom
Website
- Description: Provider of formulation development, clinical pharmacology, and clinical-to-commercial manufacturing. Services span preformulation; small-batch supply to accelerate POC; 14-day make-test cycles in humans; process development and scale-up through Phase II/III; commercial manufacturing for ANDA/NDA/MAA/Japanese NDA; and Translational Pharmaceutics integrating formulation, adaptive GMP manufacturing, and clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quotient Sciences company profile →
Kendle
HQ: United States
Website
- Description: Provider of global clinical research and full-range clinical development services for the biopharmaceutical industry, offering solutions that reduce cycle times and accelerate delivery of life-enhancing products to market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kendle company profile →
Endeavor Clinical Trials
HQ: United States
Website
- Description: Provider of research and clinical trials specializing in surgical, orthopedic, and specialty medicine, based in San Antonio, Texas, with over 20 years of experience; one of 8 portfolio research units.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endeavor Clinical Trials company profile →
MedPharm
HQ: United Kingdom
Website
- Description: Provider of topical and transdermal product design and formulation development services, offering unique, cost-effective performance testing models to reduce risk and accelerate development for generic and proprietary pharmaceutical customers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedPharm company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Presidio Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Presidio Medical
2.2 - Growth funds investing in similar companies to Presidio Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Presidio Medical
4.2 - Public trading comparable groups for Presidio Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →